NBSE insider transactions
NeuBase Therapeutics Inc. (NBSE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for NBSE
- SEC Form 5: Symetryx Corp disposed of 0 shares5 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Symetryx Corp sold $375,620 worth of shares (282,445 units at $1.33), closing all direct ownership in the company4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 3: New insider Symetryx Corp claimed ownership of 190,481 shares (Amendment)3/A - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Symetryx Corp sold $336,731 worth of shares (207,075 units at $1.63), decreasing direct ownership by 30% to 472,926 units4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Symetryx Corp bought $59,732 worth of shares (61,076 units at $0.98), increasing direct ownership by 10% to 680,081 units4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 3: New insider Symetryx Corp claimed ownership of 618,925 shares3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Stephan Dietrich A exercised 93,234 shares at a strike of $0.024 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Branning Todd P. was granted 54,200 shares, increasing direct ownership by 181% to 84,200 units4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Stephan Dietrich A was granted 153,000 shares4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Stephan Dietrich A converted options into 655,000 shares4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Branning Todd P.4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Stephan Dietrich A exercised 750,000 shares at a strike of $0.004 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Richman Eric I4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Prendergast Franklyn G4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Mcdougall Gerald J4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Goldstein Dov A Md4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Ende Eric J4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Mann William Roland bought $11,904 worth of shares (6,200 units at $1.92), increasing direct ownership by 124% to 11,200 units4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Branning Todd P. bought $18,100 worth of shares (10,000 units at $1.81), increasing direct ownership by 50% to 30,000 units4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Branning Todd P. bought $33,600 worth of shares (20,000 units at $1.68)4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Richman Eric I bought $6,352 worth of shares (3,880 units at $1.64)4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Mann William Roland4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Rojas-Caro Sandra4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Stephan Dietrich A4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Branning Todd P.4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 3 filed by new insider Branning Todd P.3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Stephan Dietrich A exercised 42,250 shares at a strike of $0.004 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Ende Eric J4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 3 filed by new insider Ende Eric J3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Mann William Roland4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Goldstein Dov A Md4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Prendergast Franklyn G4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Mcdougall Gerald J4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Richman Eric I4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: GOLDSTEIN DOV A MD bought $38,000 worth of Common Stock (8,000 units at $4.75)4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by Rojas-Caro Sandra4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by NeuBase Therapeutics, Inc.4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 3 filed by NeuBase Therapeutics, Inc.3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 3 filed by NeuBase Therapeutics, Inc.3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4 filed by McDougall Gerald J4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 3 filed by McDougall Gerald J3 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Stephan Dietrich A bought $60,000 worth of Common Stock (12,000 units at $5.00)4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: RICHMAN ERIC I bought $25,000 worth of Common stock (5,000 units at $5.00)4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: GOLDSTEIN DOV A MD bought $60,000 worth of Common Stock (12,000 units at $5.00)4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)
- SEC Form 4: Mann William Roland bought $25,000 worth of Common Stock (5,000 units at $5.00)4 - NeuBase Therapeutics, Inc. (0001173281) (Issuer)